Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and Prosperity
February 14, 2025 11:52 ET
|
Tevogen Bio Inc
CEO of Tevogen Bio, Dr. Saadi addresses short selling and its potential impact on the nation’s health and prosperity. Reaffirms commitment to shareholders.
DriveItAway Holdings, Inc. Secures a Credit Line Guaranty of 4 Million Dollars from Industry Leader Menachem Light, Who Will Chair the Board of Advisors
February 13, 2025 08:33 ET
|
DriveItAway Holdings, Inc.
Philadelphia, PA, Feb. 13, 2025 (GLOBE NEWSWIRE) -- - The Credit Line Guaranty of $4 Million is to Further the DriveItAway Mission to Solve the Personal Transportation Problem of Entry Level...
Wilbur You and You Capital Investment Firm Partner with Sol Nutrition, Inc. to Revolutionize Herbal Supplements
February 12, 2025 08:08 ET
|
You Capital LLC
You Capital Investment Firm, led by Managing Partner Wilbur You, is proud to announce its strategic equity partnership with Sol Nutrition, Inc.
Mattermost and Qrypt Announce Joint Solution for Quantum-Secure Communications in Defense and Intelligence Applications
February 12, 2025 06:00 ET
|
Mattermost
Palo Alto, California, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Mattermost, the leading collaborative workflow platform for defense, intelligence, security and critical infrastructure, and Qrypt, a pioneer...
Survivor Healthcare Joins Together for Supportive Cancer Care
February 11, 2025 08:08 ET
|
Survivor Healthcare
Survivor Healthcare joins Together for Supportive Cancer Care to expand access to early supportive cancer care through digital health innovation.
Digital Science announces Catalyst Grant winners, rewarding innovations to safeguard research integrity
February 11, 2025 07:00 ET
|
Digital Science
Digital Science has awarded its latest Catalyst Grants to two teams, supporting innovative technology ideas aimed at safeguarding research integrity.
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront
February 11, 2025 01:15 ET
|
Novartis Pharma AG
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in...
BioAstra Unveils "Twin Astra": Pioneering Deep-Space Medical Research Program Set to Transform Space Exploration and Earth-Based Medicine
February 10, 2025 15:33 ET
|
BioAstra
BioAstra Announces "Twin Astra" – A Groundbreaking Deep-Space Medical Research Program
AtmosZero Opens New Factory in Colorado to Deliver Decarbonized Steam Globally
February 10, 2025 08:00 ET
|
AtmosZero, Inc.
AtmosZero has opened its first 100,000 square-foot manufacturing factory in Colorado and appointed Jim Barnhart as chief operating officer.
Unlocking AI’s Full Potential: EXL's "AI in Action" Event Will Showcase Real-World Strategies to Scale AI for Business Leaders in ANZ
February 09, 2025 17:30 ET
|
Exlservice Holdings, Inc.
EXL's "AI in Action" Event Will Showcase Real-World Strategies to Scale AI for Business Leaders in ANZ